伊马替尼诱发的泛发性白癜风。 - Suppr | 超能文献

Imatinib-induced generalized vitiligo.

作者信息

Jain Ankur

机构信息

Assistant Professor, Haematology, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, India.

出版信息

Br J Haematol. 2022 Jun;197(5):511. doi: 10.1111/bjh.18096. Epub 2022 Mar 14.

DOI:10.1111/bjh.18096

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Imatinib-induced generalized vitiligo.伊马替尼诱发的泛发性白癜风。

Br J Haematol. 2022 Jun;197(5):511. doi: 10.1111/bjh.18096. Epub 2022 Mar 14.

2

Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment.接受甲磺酸伊马替尼治疗的儿科患者出现白癜风样皮损和皮肤弥漫性变浅：一项无创比色评估

Pediatr Dermatol. 2006 Mar-Apr;23(2):175-8. doi: 10.1111/j.1525-1470.2006.00208.x.

3

PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.血小板衍生生长因子受体α启动子多态性及表达模式影响慢性髓性白血病患者伊马替尼诱导的血小板减少症的发生风险：一项来自印度的研究。

Tumour Biol. 2017 Oct;39(10):1010428317713857. doi: 10.1177/1010428317713857.

4

Hypertrophic osteoarthropathy with imatinib therapy.伊马替尼治疗相关的肥大性骨关节病

Intern Med J. 2015 Oct;45(10):1088-90. doi: 10.1111/imj.12858.

5

A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients.一项探索慢性髓性白血病患者中ABCB1、ABCG2、OCT1基因多态性及血药谷浓度与甲磺酸伊马替尼所致血小板减少症相关性的研究。

Cancer Chemother Pharmacol. 2015 Dec;76(6):1185-9. doi: 10.1007/s00280-015-2905-6. Epub 2015 Nov 6.

6

Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1.伊马替尼诱导的胃肠道间质瘤（GIST）患者眼部副作用与表皮生长因子受体（EGFR）、有机阳离子转运体2（SLC22A1）、有机阳离子转运体5（SLC22A5）和ATP结合盒转运蛋白B1（ABCB1）的变异有关。

Pharmacogenomics J. 2018 May 22;18(3):460-466. doi: 10.1038/tpj.2017.40. Epub 2017 Aug 1.

7

Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.一名接受甲磺酸伊马替尼治疗的成年患者出现白癜风样皮损。

Leuk Res. 2009 Aug;33(8):e104-5. doi: 10.1016/j.leukres.2008.12.023. Epub 2009 Feb 20.

8

Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors.伊马替尼血药浓度与单核苷酸多态性与胃肠道间质瘤患者药物不良反应的关系。

Mol Cancer Ther. 2018 Dec;17(12):2780-2787. doi: 10.1158/1535-7163.MCT-18-0498. Epub 2018 Oct 3.

9

Multiple genes and locus interactions in susceptibility to vitiligo.多种基因和基因座相互作用与白癜风易感性相关。

J Invest Dermatol. 2010 Mar;130(3):643-5. doi: 10.1038/jid.2009.403.

10

Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors.甲磺酸伊马替尼诱导一名复发性胃肠道间质瘤患者白癜风皮损重新色素沉着。

J Am Acad Dermatol. 2008 Nov;59(5 Suppl):S80-3. doi: 10.1016/j.jaad.2008.06.029.

引用本文的文献

1

Targeted therapies induced depigmentation: a review.靶向治疗引起的色素脱失：综述

Front Immunol. 2025 Aug 8;16:1625738. doi: 10.3389/fimmu.2025.1625738. eCollection 2025.

2

Skin Hypopigmentation in Hematology Disorders.血液系统疾病中的皮肤色素减退

Hematol Rep. 2024 Jun 4;16(2):354-366. doi: 10.3390/hematolrep16020036.